Antibacterial, Synergistic and β-lactamase Inhibitory Activity of Oroxylem indicum:

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 17

Abstract

Aims: The study was aimed to evaluate the antibacterial, synergistic and β-lactamase inhibitory potential of O. indicum against ampicillin resistant and Extended Spectrum β-lactamase (ESBL) producing bacterial strains. Methods: Bacterial strains were screened for ampicillin resistance and ESBL production by disk diffusion method and modified double disc synergy test respectively. Antibacterial and synergistic activities of O. indicum methanol extract and ethyl acetate sub fraction of methanol extract were explored by agar well diffusion method and Checkerboard method respectively. Extracts were subjected to Gas chromatography and Mass spectroscopy (GC-MS) analysis to identify the bioactive compounds. Molecular docking studies were carried out to verify the β-lactamase inhibitory potential of the bioactive compounds. Results: All bacterial strains were found to be resistant to ampicillin and only one strain was detected as ESBL positive. Ethyl acetate sub fraction exhibited strong antibacterial and synergistic activity than the methanol extract. Zone of inhibition and Minimum inhibitory concentration for ethyl acetate sub fraction was 16 mm and 15mg/ml respectively. In vitro interactions between plant extracts and ampicillin evaluated in terms of fractional inhibitory concentration (FIC) indices revealed synergistic effects of plant extracts. The molecular docking studies of major bioactive compounds depicted by GC-MS analysis revealed that Wogonin, a flavonoid (GLIDE Score-5.77) possessed the best inhibitory profile against β–lactamase. Conclusion: Synergistic activity of O. indicum may be attributed to the β–lactamase inhibitory potential of the bioactive compounds present in the extract. The findings provide substantial basis for the future use of O. indicum crude extracts as potential antibacterial and antibiotic modulating agent.

Authors and Affiliations

Anupma Malik, Sheema Bai, Leena Seasotiya, Pooja Bharti, Sunita Dalal

Keywords

Related Articles

Effect of Drying Methods on the Powder and Compaction Properties of Microcrystalline Cellulose Derived from Cocos nucifera

Aim: This work aims at investigating the effect of drying methods on the powder and compaction properties of microcrystalline cellulose (MCC) obtained from the matured fruit husk of Cocos nucifera (CN). Study Design: Ex...

Investigation of Colorant FD&C Yellow No. 5 Stability in Pharmaceutical Syrup Containing Ascorbic Acid and the Optimal Storage Condition

Stability of colorant FD&C Yellow No. 5 and ascorbic acid (AA) in pharmaceutical KndCold syrup under different storage conditions (Standard conditions, temperature variation, sunlight presence, and sodium hydroxide addit...

Lipid Charecterization and Fatty Acid Profiles of Clarius batrachus and Its Defense Activity

Innate Defense Components were being useful to identify and understand their mode of action on microbial pathogens. The present study portrays the qualitative and quantitative determination of endogenous lipids from the...

Drying Kinetics of Gum Karaya (Sterculia urens) Using Convective Air Dryer

The present study was aimed to investigate the drying kinetics of gum karaya (S. urens). Three grades of gum (I, II, III) were dried using a cabinet-type convective dryer. Particle size equivalent to US Sieve size-6 and...

In vitro Cytotoxicity of Scopoletin Derived from Eupatorium laevigatum Lam.

Aims: Eupatorium laevigatum Lam. is commonly used as anti-inflammatory, antiseptic, anti-rheumatic, and in the treatment of colds and ulcers. The present study aimed to characterize the active fractions of the aerial par...

Download PDF file
  • EP ID EP344611
  • DOI 10.9734/BJPR/2014/12343
  • Views 104
  • Downloads 0

How To Cite

Anupma Malik, Sheema Bai, Leena Seasotiya, Pooja Bharti, Sunita Dalal (2014). Antibacterial, Synergistic and β-lactamase Inhibitory Activity of Oroxylem indicum:. Journal of Pharmaceutical Research International, 4(17), 2033-2045. https://www.europub.co.uk/articles/-A-344611